Adjusted green HPLC determination of nirmatrelvir and ritonavir in the new FDA approved co-packaged pharmaceutical dosage using supported computational calculations

The greening of analytical methods has gained interest in the quantitative analysis field to reduce environmental impact and improve safety health conditions for analysts. Nirmatrelvir plus ritonavir is a new FDA approved co-packaged medication developed for the treatment of COVID-19. The aim of thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Imam, Mohamed S., Batubara, Afnan S., Gamal, Mohammed, Abdelazim, Ahmed H., Almrasy, Ahmed A., Ramzy, Sherif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811874/
https://www.ncbi.nlm.nih.gov/pubmed/36599900
http://dx.doi.org/10.1038/s41598-022-26944-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811874/
https://www.ncbi.nlm.nih.gov/pubmed/36599900
http://dx.doi.org/10.1038/s41598-022-26944-y

Ejemplares similares